creatinine and glp 1 GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney disease GLP1-GIP receptor co-agonists: a promising

Oral semaglutide drops and sublingual semaglutide offer needle-free options for patients who prefer non-injectable formats

One study found a type of weight loss surgery known as sleeve gastrectomy was associated with a decrease in shoe size a year later.

Novo Nordisk and Eli Lilly hold uniquely dominant positions, with competition intensifying as pharmaceutical challengers increase investment across all GLP-1 ecosystem layers

Maintaining weight loss requires a long-term commitment to healthy habits and may involve ongoing support from healthcare providers or weight loss programs

Pfizer Makes Strides in Developing Once-Daily Oral GLP-1 Agonist Danuglipron Pfizer Inc